Insider Transactions in Q3 2022 at Idera Pharmaceuticals, Inc. (IDRA)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 28
2022
|
Nova Quest Co Investment Fund Xv, L.P. Director |
BUY
Other acquisition or disposition
|
Direct |
5
+50.0%
|
-
|
|
Sep 28
2022
|
Ronald J Wooten Director |
BUY
Other acquisition or disposition
|
Indirect |
5
+50.0%
|
-
|
|
Sep 28
2022
|
John Clayton Taylor CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,171,214
+50.0%
|
-
|
|
Sep 28
2022
|
Daniel Salain CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,171,214
+50.0%
|
-
|
|
Sep 28
2022
|
Andrew R Jordan CHIEF STRATEGY OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
651,364
+50.0%
|
-
|
|
Sep 22
2022
|
Pillar Invest Corp > 10% Shareholder |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Indirect |
1,533,159
+17.42%
|
$0
$0.01 P/Share
|
|
Jul 01
2022
|
Michael R Dougherty |
BUY
Grant, award, or other acquisition
|
Direct |
50,086
+15.03%
|
$0
$0.44 P/Share
|